$TAK TAK-676 as Single Agent (SA) and in Combination With $MRK Pembrolizumab in Advanced or Metastatic Solid Tumors
TAK-676 (from Curadev) will be the third IV STING agonist in clinical trial, with $GSK $SBPH
https://t.co/YETogzBryI